← Evidence map

ReviewPharmaceutics2023

Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na).

Ana Monfort-Vengut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37111716